Hip and femoral fracture anticoagulation surgical timing evaluation
There has been a focus on improving the care of patients sustaining hip fractures, concentrating on rapid assessment, optimisation for surgery, early surgery, and rehabilitation. This has led to significant improvements in outcome for this patient group as a whole.
However a large number of these patients have not experienced the same degree of benefit, namely those who take anticoagulant medications (e.g., warfarin). Hip fracture surgery is usually delayed for these patients.
Evaluating the current national peri-operative management of anticoagulated hip fracture patients is important to determine scope for improvement and whether further work on this topic is required.
What we are doing
The HASTE Study is a multi-centre prospective service evaluation that will evaluate the epidemiology and management of hip and femoral fracture patients on oral anticoagulant medications.
Data on anticoagulated and non-anticoagulated hip and femoral fracture patients will be collected prospectively by collaborators at participating units over three months.
Mr Will Eardley
Mr Muhamed Alanie
AO UK and I
South Tees Hospitals NHS Foundation Trust in collaboration with CORNET
In set up